Zahner H, Striebel H P, Schütze H R, Sänger I, Müller H A, Schultheiss K
Institute for Parasitology, Justus Liebig University Giessen, FRG.
Trop Med Parasitol. 1988 Dec;39(4):284-90.
The spectrum of antimicrofilarial activities of eighteen 2-tertbutylbenzazole derivatives was evaluated comparatively in Mastomys natalensis infected with Litomosoides carinii, Acanthocheilonema viteae, Brugia malayi or B. pahangi. The minimal effective dose (DEM) against microfilariae (greater than 95% reduction of microfilariae counts in the peripheral blood) was determined on day 3 (DEM-3), on day 7, 14, 21, 28 and 42 (DEM-7, DEM-14, DEM-21, DEM-28 and DEM-42) after the first treatment. All compounds were effective against the microfilariae of all 4 species. The benzoxazole derivatives were invariably less potent than the corresponding benzothiazole analogues. Upon repeated oral treatment (once daily [o.d.] for five days) the DEM-7 of the benzoxazoles varied depending on the species and on the chemical structure between 25 mg/kg o.d. x 5 and greater than 100mg/kg o.d. x 5 days. Within the benzothiazole series the DEM-7 varied between 6.25 mg/kg o.d. x 5 and 100 mg/kg x 5. In all but 5 of the 40 parasite-compound combinations of the benzothiazoles the 5-methoxy-derivates were more effective than the 5-methyl analogues. Similar differences were found with the eight benz-oxazoles tested. The lowest DEM-7 was observed with compound CGP 20308 which is 2-tert-butyl-5-methoxy-6-isothio-cyanatobenzothiazole and with compound CGP 20376 which is 3-(2-tert-butyl-5-methoxy-benzothiazol-6-yl] amino-thiocabo-nylthio) propionic acid.(ABSTRACT TRUNCATED AT 250 WORDS)
在感染了卡里尼丝虫、旋盘尾丝虫、马来布鲁线虫或彭亨布鲁线虫的南非多乳鼠中,对18种2-叔丁基苯并唑衍生物的抗微丝蚴活性谱进行了比较评估。在首次治疗后的第3天(最小有效剂量-3,DEM-3)、第7天、第14天、第21天、第28天和第42天(DEM-7、DEM-14、DEM-21、DEM-28和DEM-42)确定了针对微丝蚴的最小有效剂量(外周血中微丝蚴计数减少大于95%)。所有化合物对所有4种物种的微丝蚴均有效。苯并恶唑衍生物的效力始终低于相应的苯并噻唑类似物。经反复口服治疗(每日一次[o.d.],共5天)后,苯并恶唑的DEM-7因物种和化学结构而异,介于25mg/kg o.d.×5和大于100mg/kg o.d.×5天之间。在苯并噻唑系列中,DEM-7介于6.25mg/kg o.d.×5和100mg/kg×5之间。在苯并噻唑的40种寄生虫-化合物组合中,除5种外,5-甲氧基衍生物均比5-甲基类似物更有效。在测试的8种苯并恶唑中也发现了类似差异。化合物CGP 20308(2-叔丁基-5-甲氧基-6-异硫氰酸苯并噻唑)和化合物CGP 2037(3-(2-叔丁基-5-甲氧基-苯并噻唑-6-基]氨基-硫代羰基硫代)丙酸的DEM-7最低。(摘要截于250字)